Biotech News
Kineticos Unveils Kinvard Bio, a Biotech Focused on Drug-Resistant Infections
Kineticos Life Sciences has announced the launch of Kinvard Bio, Inc., a biotech company dedicated to developing new antibiotics to combat antimicrobial resistance (AMR). The company is built on research licensed exclusively from Harvard University’s Myers Lab and is financially supported by Kineticos
25 February 2025